Funding Rounds
T3 Pharmaceuticals Series C (2020, $26M)
T3 PharmaceuticalsTreatments that improve the lives of cancer patients with innovative approaches.
Summary
Stage: Series C
Raised Amount: $26.73M
Raised Date: 2020-01-01
Stage: Series C
Raised Amount: $26.73M
Raised Date: 2020-01-01